Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Falco Holdings Co's earnings per share without non-recurring items for the
three
months ended in Mar. 2026 was 円52.12.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 円174.67.
During the past 12 months, Falco Holdings Co's average earnings per share (NRI) Growth Rate was 6.00% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was -3.00% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was -6.80% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 6.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Falco Holdings Co's EPS without NRI or its related term are showing as below:
TSE:4671'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -74.4 Med: 6.6 Max: 360
Current: -3
During the past 13 years, Falco Holdings Co's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 360.00% per year. The lowest was -74.40% per year. And the median was 6.60% per year.
TSE:4671's 3-Year EPS without NRI Growth Rate is ranked worse than 68.99% of 158
companies
in the Medical Diagnostics & Research industry
Industry Median: 10.75
vs TSE:4671: -3.00
Falco Holdings Co's EPS (Diluted) for the
three
months ended in Mar. 2026 was 円60.10.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円200.06.
Falco Holdings Co's EPS (Basic) for the
three
months ended in Mar. 2026 was 円60.59.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was 円201.10.
Falco Holdings Co (TSE:4671) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Falco Holdings Co EPS without NRI Related Terms
Falco Holdings Co EPS without NRI Historical Data
* Premium members only.
The historical data trend for Falco Holdings Co's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4671 vs TMO, DHR, IDXX: EPS without NRI Comparison
For the Diagnostics & Research subindustry, Falco Holdings Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Falco Holdings Co PE Ratio without NRI vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Falco Holdings Co's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Falco Holdings Co's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円174.67
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Falco Holdings Co (TSE:4671) has a EPS without NRI of 円174.67 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Falco Holdings Co and its competitors. According to the industry distribution chart, Falco Holdings Co ranks #109 out of 158 companies in the Medical Diagnostics & Research industry, placing it in the top 69%.
Is Falco Holdings Co's EPS without NRI too high?
Falco Holdings Co's current EPS without NRI is 円174.67. Based on the distribution chart, Falco Holdings Co ranks #109 out of 158 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Falco Holdings Co has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Falco Holdings Co's EPS without NRI compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Falco Holdings Co ranks #109 out of 158 companies for EPS without NRI. This places Falco Holdings Co in the lower half of its industry. The industry median EPS without NRI is 10.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Diagnostics & Research company?
The median EPS without NRI among Medical Diagnostics & Research companies is 10.75, based on 158 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Falco Holdings Co and its competitors. For the Medical Diagnostics & Research industry, the median EPS without NRI is 10.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Falco Holdings Co's current EPS without NRI is 円174.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Falco Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Falco Holdings Co (TSE:4671) is currently considered Fairly Valued. The stock's GF Value™ is 円2,528.51, compared to a current price of 円2,672.00 — trading 5.7% above its estimated fair value. The current EPS without NRI is 円174.67. Falco Holdings Co's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Falco Holdings Co (TSE:4671), the current EPS without NRI is 円174.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Falco Holdings Co (TSE:4671) Overvalued in 2026?
Based on GuruFocus' analysis, Falco Holdings Co stock appears to be overvalued.
The current stock price of 円2,672.00 is trading 5.7% above its estimated GF Value™ of 円2,528.51.
GuruFocus considers Falco Holdings Co to be Fairly Valued.
Key valuation signals for TSE:4671:
EPS without NRI: 円174.67
GF Value™: 円2,528.51 vs. price of 円2,672.00 (5.7% above fair value)
No single metric tells the full story. See the TSE:4671 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Falco Holdings Co Ltd provides testing services. The company is engaged in providing clinical testing and genetic testing services, testing in clinical research and clinical trials, food sanitation, and environmental testing, and pharmacy business. It also engaged in providing information technology business.
71GF Score
Get the complete analysis for TSE:4671
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4671 has been successfully added to your 
